Cellect Biotechnology Ltd. (NASDAQ: APOP)Complementary equity research reports on Cellect Biotechnology Ltd. Report Type Publish Date link Q3 2019 Update 24 December 2019 Download Q2 2019 Update 3 September 2019 Download Q1 2019 Update 28 May 2019 Download 2018 Annual Update 8 April 2019 Download Q3 2018 Update 13 December 2018 Download Immediate Report 17 October 2018 Download Q2 2018 Update 20 August 2018 Download Q1 2018 Update 30 May 2018 Download Immediate Report 31 January 2018 Download Immediate Report 10 January 2018 Download Q3 2017 Update 19 December 2017 Download Immediate Report 11 November 2017 Download On September 3 2017 Cellect voluntarily delisted its shares from trading on the TASE, and withdrew from the TASE Analysis program. Hereafter all equity research is governed by an agreement between Frost & Sullivan and the Company and concerns the securities listed on the NASDAQ. Report Type Publish Date link Q2 2017 Update 30 August 2017 Download Q2 2017 Update – Hebrew Appendix 30 August 2017 Download Q2 2018 Update 20 August 2018 Download Immediate Report 14 June 2017 Download Immediate Report – Hebrew Appendix 14 June 2017 Download Q1 2017 Update 7 June 2017 Download Q1 2017 Update – Hebrew Appendix 7 June 2017 Download Initiation of Coverage 27 April 2017 Download Initiation of Coverage – Hebrew Appendix 27 April 2017 Download
